Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

  • Entrada Therapeutics Inc (NASDAQ:TRDA) shares dipped 33.5% to $13.22 after the company said it received a clinical hold notice from the FDA regarding its Investigational New Drug Application for ENTR-601-44 for the potential treatment of Duchenne muscular dystrophy.
  • Arcus Biosciences, Inc. (NYSE:RCUS) declined 28.1% to $21.92. Gilead Sciences and Arcus Biosciences announced results from the fourth interim analysis of the ARC-7 Phase 2 study for metastatic non-small cell lung cancer with PD-L1 tumor proportion score ≥50% without epidermal growth factor receptor or anaplastic lymphoma kinase mutations.
  • BioVie Inc. (NASDAQ:BIVI) declined 27% to $7.27.
  • Embecta Corp. (NASDAQ:EMBC) dropped 14.8% to $27.65 after the company reported a decline in Q4 sales.
  • Vigil Neuroscience, Inc. (NASDAQ:VIGL) dropped 14.5% to $10.51.
  • Mullen Automotive, Inc. (NASDAQ:MULN) declined 14.1% to $0.2330.
  • FuelCell Energy, Inc. (NASDAQ:FCEL) fell 13.8% to $2.81 after the company reported worse-than-expected Q4 EPS and sales results.
  • iTeos Therapeutics, Inc. (NASDAQ:ITOS) dropped 13.2% to $17.05.
  • Ark Restaurants Corp. (NASDAQ:ARKR) fell 13.1% to $15.74 after the company reported a sharp decline in quarterly earnings.
  • Summit Therapeutics Inc. (NASDAQ:SMMT) dropped 12.8% to $3.7707.
  • Embecta Corp. (NASDAQ:EMBC) fell 12.4% to $28.47 after the company reported Q4 earnings results.
  • ioneer Ltd (NASDAQ:IONR) dropped 12.3% to $11.96.
  • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) fell 10.5% to $8.01 after the company announced a proposed $75 million public offering.
  • Century Therapeutics, Inc. (NASDAQ:IPSC) declined 9.5% to $6.31.
  • Horizon Technology Finance Corporation (NASDAQ:HRZN) fell 8.3% to $11.02 after Keefe, Bruyette & Woods downgraded the stock from Market Perform to Underperform and lowered its price target from $11.5 to $10.5.
  • Sintx Technologies, Inc. (NASDAQ:SINT) dropped 7% to $7.25. Sintx Technologies announced a 1-for-100 reverse stock split, effective December 20, 2022.

Check out this: US Stocks Edge Higher; Dow Rises 50 Points

Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading Ideasbig losersTop Losers